Key points are not available for this paper at this time.
Design
Editorial
Highlights the methodological challenge that composite endpoints in clinical trials may obscure significant variations among their individual components.
Use of composite end points as the main outcome in randomised trials can hide wide differences in the individual measures. How should you apply the results to clinical practice?
No takes yet. Share an insight, caveat, or question.
Montori et al. (2005) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: